Mast cells induce epithelial-to-mesenchymal transition and migration in non-small cell lung cancer through IL-8/Wnt/β-catenin pathwayJingjing Qu, Nong Yang|Journal of Cancer|2019Cited by 21
Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancerLianxi Song, Yongchang Zhang, Liang Zeng et al.|Communications Medicine|2022Cited by 20
Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker studyYongchang Zhang, Nong Yang|BMC Cancer|2022Cited by 19
Expert consensus on treatment for stage III non‐small cell lung cancerYi‐Long Wu, Yun Fan, Ying Cheng et al.|Medicine Advances|2023Cited by 18
PIM1 inhibitor synergizes the anti-tumor effect of osimertinib via STAT3 dephosphorylation in EGFR-mutant non-small cell lung cancerZiyi Sun, Nong Yang|Annals of Translational Medicine|2020Cited by 17